Scandinavian Biopharma Holding

Scandinavian Biopharma Holding develops together with the American global health non-profit organization, PATH Vaccine Solutions and researchers at the University of Gothenburg, a new travellers’ diarrhoea vaccine, an oral ETEC vaccine. The company has extensive experience in the field of vaccine and drug development, process development, commercial production and marketing & sales. The company offers contract research services, including process development and are actively looking for additional products to expand their current product portfolio.